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The Hypoxic Response: Minireview
Huffing and HIFing
Karen Guillemin and Mark A. Krasnow the substantial increase in carbohydrate consumption
that occurs to compensate for its inefficient utilizationDepartment of Biochemistry
under anaerobic conditions. When oxygen is unavailableStanford University School of Medicine
as the final electron acceptor in the respiratory chain,Stanford, California 94305
the cell must abandon oxidative phosphorylation and
rely solely on glycolysis for energy production. The
switch to anaerobic metabolism, we are taught, is regu-
Since Joseph Priestley's demonstration in 1774 of the lated by energy pathway metabolites acting on glyco-
deleterious effects of a burning candle on a mouse in a lytic enzymes. For example, phosphofructokinase is al-
bell jar, we have known that oxygen is essential for losterically inhibited by ATP and inhibition is reversed
animal life. Only recently, however, have we begun to by AMP. This is, however, just a small part of the way
understand how animal cells sense when oxygen is lim- in which each cell deals with inadequate oxygen levels.
iting and respond to the crisis of hypoxia. Cellular re- Hypoxic cells sense diminishing oxygen levels well be-
sponses range from rapid changes in carbohydrate me- fore their ATP pools are depleted, and respond with
tabolism to permanent restructuring of their blood a self-imposed austerity program to curb their energy
supply. Remarkably, studies of these diverse phenom- usage by shutting down nonessential cell functions (Ho-
ena have recently converged on a common pathway chachka et al., 1996). Not only is hypoxia a signal for
employed by cells to sense hypoxia and activate specific energy conservation, but in the past few years it has
genes to deal with the crisis. Not only is this pathway been found to trigger expression of a select set of genes
crucial for normal tissue physiology, but its failure can (Fandrey, 1995). These include specific isoforms of gly-
contribute to diseases such as myocardial infarction colytic enzymes and glucose transporters that function
and anemia, and its misregulation can lead to retinopa- better at low oxygen. Another is the EPO gene, and it
thy and tumor growth. Here we describe the recent ad- is the study of this gene that has led to a considerably
vances in the molecular response to hypoxia and the expanded view of the hypoxic response.
identification of the HIF-1 transcription factor as a cen- Mechanism of EPO Induction by Hypoxia
In 1890, after hiking in themountains of Peru, the histolo-tral component in the hypoxic response pathway.
gist Viault documented an increase in his erythrocyteThe Body's Response to Hypoxia
density and attributed it to the lower partial oxygen pres-To place the molecular advances in a physiological con-
sure at high altitude. The molecular basis of this re-text, it is useful to consider the many ways that our
sponse had to await a century that included the purifica-bodies are equipped to deal with inadequate tissue oxy-
tion of the erythropoietic factor EPO and the discoverygenation. Someone experiencing hypoxia of a less se-
that it binds the EPO receptor on the surface of erythro-vere form than Priestley's bell jar±bound mouseÐfor
cytic progenitors to stimulate their proliferation and dif-example a sea level±acclimated scientist at a Keystone
ferentiation into red blood cells. With the cloning of themeeting at 9,000 feetÐwill experience rapid breathing,
EPO gene in 1985, recombinant EPO became widelyincreased circulation, and the buildup of muscle lactic
available for anemic patients and ambitious athletes,acid while hiking, and, if the conference lasts several
and investigators were able to show that hypoxia regu-days, will exhibit an increase in red blood cell and hemo-
lates EPO expression primarily at the level of transcrip-globin counts and perhaps a proliferation of blood capil-
tion. The challenge of understanding the hypoxic induc-laries. Such responses aredesigned todecrease cellular
tion of EPO would be surmounted in the next decadeoxygen need and dependence on oxygen, and to in-
with several major advances including an initial charac-crease tissue oxygen supply. Some of the responses
terization of a cellular oxygen sensor and the identifica-are intrinsic to all hypoxic cells, indicating that each
tion of the hypoxia-inducible transcription factor HIF-1.
cell has its own oxygen-sensing system, while other
In a seminal paper, Goldberg et al. (1988) found that
responses are mediated by more centralized sensors in
the EPO gene is induced by hypoxia in liver cell lines,
the body that monitor global oxygen levels and cause and the induction displayed distinctive pharmacological
system-wide changes in tissue oxygen delivery. For ex- characteristics suggesting the involvement of a special-
ample, when cells of the carotid body detect subnormal ized cellular oxygen sensor. Induction was insensitive to
oxygen levels in the carotid arteries, they propagate electron transport poisons such as potassium cyanide,
dopaminergic signals to the brain to increase breathing indicating that the cells were not measuring oxygen lev-
and thus the oxygen saturation of the blood. Another els simply by failure of the respiratory chain. Instead
example is cells of the developing liver and adult kidney they found that EPO expression could be induced by
that regulate the blood's oxygen carrying capacity by divalent metals like cobalt that mimic ferrous iron and
secreting the glycoprotein hormone erythropoietin could be blocked by carbon monoxideÐhallmarks of
(EPO), which stimulates red blood cell and hemoglobin the involvement of a heme-containing protein in oxygen
production. sensing (see below). Theyalso found that hypoxic induc-
The Molecular Response to Hypoxia: tion of EPO was obliterated by the translational inhibitor
The Classical View cycloheximide, indicating that this hypoxic response
Every biochemistry student learns the classical re- pathway requires a round of de novo protein synthesis.
sponse of an oxygen-starved cell, first described by The search for the molecules that conferred this oxy-
gen-dependent regulation of EPO expression was ledLouis Pasteur in yeast and called the Pasteur effect, as
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by Semenza, Ratcliffe, Caro, and their colleagues. By pharmacology as EPO induction, suggesting that they
studying the expression of EPO reporter genes in hepa- are controlled by a common oxygen sensing pathway
tocytes and transgenic mice, they honed in on an ap- mediated through HIF-1.
proximately 50-nucleotide enhancer element in the 39 The important role of HIF-1 in the hypoxic response
end of the gene that conferred hypoxic induction (Se- was recently established with hepatocyte cell lines se-
menza, 1996). Semenza's group went on to discover lected for absence of ARNT activity and lacking ARNT/
a transcription factor that acts through this sequence, HIF-1b protein, although the HIF-1b transcript is still
detected only in hypoxic cells, and named it hypoxia produced (Wood et al., 1996). These cells are defective
inducible factor 1 (HIF-1). for the hypoxic induction of a battery of genes including
HIF-1 binds the sequence 59-TACGTGCT-39 in the lactose dehydrogenase-A, phosphoglycerate kinase-1,
EPO enhancer, and this site-specific DNA binding activ- glucose transporter-1, and VEGF. Further support for
ity facilitated its purification and the cloning of its genes the significance of HIF-1 in vivo comes from a recent
(Wang et al., 1995a). It is an a/b heterodimer, with each study showing that induction of HIF-1 is perfectly tuned
subunit containing a basic-helix-loop-helix (bHLH) motif to physiological fluctuations in tissue oxygen levels. Ex-
and a PAS protein±protein interaction domain found pression of HIF-1 proteins and the level of HIF-1 DNA
in a variety of known or suspected transcription fac- binding activity show an exponential increase with de-
tors including the Drosophila proteins Period, Single- creasing oxygen from z5% (z35 mm Hg) to 0%, with
minded, and Trachealess, and the mammalian proteins half maximal response at z1.5% oxygen, nicely coincid-
aryl hydrocarbon receptor (AHR) and aryl hydrocarbon ing with the critical range of partial oxygen pressures
receptor nuclear translocator (ARNT). In fact, the HIF- measured for tissues in vivo (Jiang et al., 1996).
1b subunit turned out to be identical to previously The Oxygen Sensing Pathway
described ARNT protein isoforms, which function as a The induction profile of HIF-1 by oxygen shows that cells
heterodimer with AHR in the cellular response to envi- sense and respond to a continuous range of ambient
ronmental toxins such as aryl hydrocarbons. The fact oxygen pressures. The response curve is reminiscent
that the ARNT/HIF-1b subunit is involved in the induction of the classical oxygen saturation curve of hemoglobin
of two distinct pathways points to HIF-1a as the critical and, together with the pharmacological studies of induc-
hypoxia-specific component. tion of HIF-1 and its targets already discussed, suggests
HIF-1 as a Global Regulator of Hypoxic
that oxygen sensing involves a hemoprotein. The sim-
Gene Expression
plest possibility is that the sensor itself is an oxygen-
Scaling the terrain of EPO gene regulation, researchers
binding hemoprotein that undergoes an oxygen-depen-
could never have dreamed of the vista they would find
dent conformational change like hemoglobin, although
at the summit. They started in search of a regulator of
more elaborate models have also been proposed (Bunn
erythropoiesis and discovered what appears to be a
and Poyton, 1996). Such an oxygen sensor has beenglobal regulator of hypoxic gene expression. As ex-
described in the bacterium Rhizobium meliloti, a legumepected of a general regulator, HIF-1 is widely expressed
symbiote that responds to the anoxic environment inin tissues and HIF-1 activity is found in many different
the host's root nodule via a two-component regulatorycell lines, most of which do not express EPO. Indeed,
system. The oxygen sensor, FixL, is an integral mem-HIF-1 is not at all restricted to EPO regulation (Semenza,
brane heme-containing kinase whose activity is modu-1996). This was first shown by the identification of HIF-1
lated by oxygen binding (Gilles et al., 1991). In the deoxybinding sites in a number of glycolysis genes and the
conformation, the kinase phosphorylates the transcrip-demonstration that these sites can confer hypoxic regu-
tional factor, FixJ, which turns on a cascade of genelation on other genes (Semenza et al., 1994). Functional
regulation leading to expression of nitrogen fixationHIF-1 sites were subsequently found in the gene encod-
genes.ing vascular endothelial growth factor (VEGF), a potent
Clues about signal transduction from the mammalianangiogenic factor produced by oxygen-starved cells
oxygen sensor to induction of HIF-1 have also begun(Shweiki et al., 1992). VEGF binds the receptor tyrosine
to accumulate, suggesting that the pathway may involvekinases flk, flt-1, and flt-4 on vascular endothelial cells
protein phosphorylation, as in Rhizobium.General inhib-and stimulates the local proliferation of blood capillaries
itors of tyrosine kinases block induction of the HIF-1to increase oxygen delivery. Usually this is a beneficial
genes, while inhibitors of tyrosine phosphatases in-response, but it can also have grave consequences as
crease basal levels of HIF-1 proteins and HIF-1 activitywhen it allows growing tumors to overcome their limiting
(Wang et al., 1995b). A candidate tyrosine kinase up-blood supply, or when VEGF-driven angiogenesis in the
stream of HIF-1 is c-Src, which has been shown to beretina destroys vision (Folkman, 1995). The genes en-
activated by hypoxia. In c-src2 cells the hypoxic induc-coding inducible nitric oxide synthase (i-NOS) and heme
tion of VEGF is substantially reduced (Mukhopadhyayoxygenase-1 (HO-1), which regulate the production of
et al., 1995). The possibility that c-Src functions up-the vasodilators nitric oxide and carbon monoxide, re-
stream of HIF-1 can be tested by examining other HIF-1spectively, also appear to be HIF-1 targets. And HIF-1
targets in c-src2 cells, and by expressing an activatedsites are present in the tyrosine hydroxylase (TH) gene,
c-Src in the ARNT/HIF-1b deficient cell lines and seeingencoding a key enzyme in dopamine synthesis and the
if the absence of HIF-1 prevents the c-Src-mediatedregulation of breathing. Thus, multiple hypoxic re-
induction of VEGF.sponses including adaptation to anaerobic metabolism,
The ARNT/HIF-1b deficient cell lines have also pro-erythropoiesis, angiogenesis, vasodilation, and possibly
vided evidence for additional factors in the hypoxiabreathing are all under the control of a single transcrip-
tion factor. Many of these HIF-1 targets show the same pathway. Because hypoxic induction of HIF-1a and -1b
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Figure 1. Model of the HIF-1 Hypoxia Re-
sponse Pathway
At normal tissue oxygen tension, O2 is bound
to a hemoprotein oxygen sensor (S´Heme).
When oxygen levels drop, oxygen dissociates
causing a change in the sensor that triggers
a signaling cascade involving protein phos-
phorylation. This leads to activation of a hy-
pothetical regulator (Factor X) and increased
expression of the HIF-1a and -1b subunits.
The HIF-1 a/b heterodimer binds and acti-
vates expression of various genes including
those encoding glycolytic enzymes (for an-
aerobic metabolism), VEGF (for angiogen-
esis), inducible nitric oxide synthase and
heme oxygenase-1 (for production of vasodi-
lators), EPO (for erythropoiesis), and possibly
tyrosine hydroxylase (for dopamine produc-
tion to increase breathing). These genes help
the cell survive at low oxygen and act to restore normal oxygen levels. Some targets of HIF-1 are induced in most hypoxic cells, while others
like EPO are only induced in specific tissues and hence must also require tissue specific regulators. For example, the orphan nuclear receptor
hepatic nuclear factor-4 is proposed to be a tissue-specific factor that works with HIF-1 to control EPO expression in the liver and kidney
(Galson et al., 1995).
transcripts can still occur in the ARNT/HIF-1b2 cells kidney induce EPO. HIF-1 must therefore function com-
binatorially with cell type±specific regulatory factors like(Wood et al., 1996), there must be another hypoxic regu-
lator upstream of HIF-1 in the pathway, which we refer the orphan receptor HNF-4 (see legend of Figure 1) to
control these specific responses. Further levels of con-to as factor X in Figure 1. Similarly, induction of some
HIF-1 targets is only partially compromised in the ARNT/ trol and feedback in the pathway may be provided by
posttranscriptional regulation of HIF-1, because theHIF-1b2 cells, indicating that factors besides HIF-1 must
contribute to their hypoxic induction. For the glucose turnover of HIF-1 transcripts and proteins is sensitive
to hypoxia, and the phosphorylation and redox state oftransporter-1 gene, part of the hypoxic induction is sen-
sitive to potassium cyanide, providing evidence for a HIF-1 protein can influence its activity (Wang et al.,
1995a, 1995b; Semenza, 1996).separate hypoxia sensing system (Ebert et al., 1995).
Some of the missing components may be found among While an outline of the HIF-1 hypoxic response path-
way is emerging, many critical questions remain. Whatthe transcription factors besides HIF-1 that can be af-
fected by hypoxia such as AP-1, NF-kB, and p53, al- are the identities of the cellular oxygen sensor and factor
X, and what is the mechanism of signaling betweenthough their functions are clearly not restricted to the
hypoxic response. Other hypoxic regulators may func- these two parts of the pathway? What are the other
hypoxic regulators that work in conjunction with or inde-tion posttranscriptionally, for example by stabilizing
hypoxically induced RNAs (Bunn and Poyton, 1996). pendently of HIF-1? We also need to better understand
the full range of cellular responses to low oxygen ten-The Molecular Response to Hypoxia:
The New View sions and how a cell coordinates the HIF-1 pathway
with other hypoxic responses such as the Pasteur effect,With the convergence of several independent areas of
hypoxia research on a common oxygen sensing path- the shutdown of nonessential cell functions, and the
most severe response, the induction of cellular suicideway, HIF-1 hasemerged as a central regulator of hypoxic
gene expression and restoration of cellular oxygen ho- by p53-mediated apoptosis (Graeber et al., 1996). Such
an understanding would facilitate the development ofmeostasis. A working model for the pathway is sche-
matized in Figure 1. Oxygen directly interacts with the medical treatments for rescuing ischemic tissues and
for destroying tumor cells.cellular oxygen sensor independently of mitochondrial
respiration, keeping the sensor inactive. When oxygen While rapid progress is likely to continue with
the current biochemical and molecular biological ap-levels drop, the deoxy form of the sensor activates a
signal that may then be transduced via protein phos- proaches, other tacks may be needed to piece together
the entire HIF-1 pathway. Hypoxia pathways are beingphorylation to factor X,which leads to increased expres-
sion of HIF-1a and -1b. The HIF-1 heterodimer in turn worked out in the yeast Saccharomyces cerevesiae (Zi-
tomer and Lowry, 1992), but they differ in a numberinduces a battery of genes involved in cellular and global
responses to hypoxia including anaerobic metabolism, of respects from the HIF pathway, and indeed the S.
cerevesiae genome lacks HIF-1 homologs. Drosophilaerythropoiesis, angiogenesis, and breathing, which
allows the cell to survive at low oxygen and helps restore may allow a traditional genetic approach because flies
and other insects exhibit characteristic responses tothe normal oxygen level.
Although all cells apparently contain the same general hypoxia, including induction of glycolytic genes and a
proliferation of the tracheal branches that deliver oxygenpathway, the end response in each cell type is individu-
ally tailored. Thus while most cells exposed to prolonged to the tissues (Manning and Krasnow, 1993), and Dro-
sophila cell extracts contain a HIF-1-like DNA bindinghypoxia will induce expression of glycolytic genes and
various angiogenic factors, only cells of the liver and activity (Nagao et al., 1996). Certain inherited human
Cell
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diseases might also provide insights into hypoxic signal-
ing. For example, several families have been identified
with consitutively high EPO levels, and some of these
could be due to mutations that cause constitutive activ-
ity of the HIF-1 pathway. Given the energetic pace of
the field and the pressing medical need to understand
the hypoxic response, we shouldn't have to hold our
breath long for answers.
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